0001062993-23-022658.txt : 20231215
0001062993-23-022658.hdr.sgml : 20231215
20231215173322
ACCESSION NUMBER: 0001062993-23-022658
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beattie John Gregory
CENTRAL INDEX KEY: 0001845679
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23357
FILM NUMBER: 231491523
MAIL ADDRESS:
STREET 1: C/O BIOANALYTICAL SYSTEMS, INC.
STREET 2: 2701 KENT AVENUE
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inotiv, Inc.
CENTRAL INDEX KEY: 0000720154
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 351345024
STATE OF INCORPORATION: IN
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 2701 KENT AVE
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906-1382
BUSINESS PHONE: 3174634527
MAIL ADDRESS:
STREET 1: 2701 KENT AVENUE
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906-1382
FORMER COMPANY:
FORMER CONFORMED NAME: BIOANALYTICAL SYSTEMS INC
DATE OF NAME CHANGE: 19970918
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-12-14
0000720154
Inotiv, Inc.
NOTV
0001845679
Beattie John Gregory
2701 KENT AVENUE
WEST LAFAYETTE
IN
47906-1382
0
1
0
0
Chief Operating Officer
0
Common Stock
2023-12-14
4
P
0
47966
3.1238
A
111761
D
Employee Stock Option (right to buy)
3.0895
2023-12-15
4
A
0
7500
0
A
2033-12-15
Common Stock
7500
7500
D
Reflects the weighted average price of 47,966 common shares purchased by the reporting person in multiple transactions on December 14, 2023 with purchase prices ranging from $2.88 to 3.30 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Represents a grant of non-qualified options, which have a three year vesting period of 40% / 30% / 30% beginning on the first anniversary of the grant date, subject to continued employment.
/s/ Beth Taylor, attorney-in-fact for John Gregory Beattie
2023-12-15